Researchers at the Brain Tumor Center Molecular Therapeutics Program seek to understand the biological mechanisms of cancer’s spread to the brain and to develop effective new ways to treat the condition.
The program was established with a $2 million gift from the Harold C. Schott Foundation and $4.5 million in additional funds from the UC College of Medicine and its Departments of Neurosurgery and Radiation Oncology and the Division of Hematology-Oncology.
The program is building a translational research and patient care program that is interdisciplinary and dedicated exclusively to tackling the growing problem of brain metastasis.
The Molecular Therapeutics Program, believed to be the first translational, metastasis-specific program of its kind in the United States, is a collaboration between the UC Gardner Neuroscience Institute and the UC Cancer Institute. It will allow UC to build a subspecialized research team that will collaborate with the existing brain tumor clinicians and surgeons to address the problem of brain metastases through translational research and original clinical trials.
Researchers seek a better understanding of how and why cancers metastasize to the brain in order to develop specific therapies to treat existing brain metastases and possibly prevent their formation.